Proteomic signature predicts the metastatic risk of primary cutaneous squamous cell carcinomas. Azimi A, Patrick E, Teh R, Sholji T, et al. J Invest Dermatol 2026 Sep 22:S0022-202X(26)03713.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Azimi A, Patrick E, Teh R, Sholji T, et al. Proteomic signature predicts the metastatic risk of primary cutaneous squamous cell carcinomas. J Invest Dermatol 2026 Sep 22:S0022-202X(26)03713.
PMID: 42772590